Microsure receives CE mark for MUSA-3 system and appoints new CEO
Dutch medical know-how firm Microsure has accepted CE marking for its MUSA-3 system and appointed Alex Joseph as its new CEO, changing Iwan van Vijfeijken.
With the CE mark, the corporate can now deploy the MUSA-3 system for scientific use throughout Europe, transferring from product improvement to a scientific medical gadget firm, the place it goals to construct proof and assist adoption by medical facilities.
Uncover B2B advertising and marketing that delivers
Mix enterprise intelligence and editorial excellence to achieve engaged professionals throughout 36 main media platforms.
Extra info
The corporate will give attention to producing scientific information at European websites, forming collaborations and evaluating how the MUSA-3 system facilitates supermicrosurgical procedures.
The system is meant to offer help throughout open super-microsurgical procedures by permitting surgeons to attain finer and extra steady hand actions.
Supposed makes use of embody supportive procedures on small anatomical constructions resembling lymphatic vessels, blood vessels and nerves, with functions in free flap surgical procedure, lymphatic procedures and peripheral nerve repairs.
The management change aligns with this shift, as Joseph steps up as CEO after making vital contributions to the event of MUSA-3. He brings expertise in surgical robotics and controlled medical gadgets.
Joseph stated: “As I step into the function of CEO, Microsure is getting into a brand new section. Now that CE Mark has been achieved, our focus is on producing scientific proof and demonstrating the worth of our know-how in apply.”
Microsure has acknowledged Iwan van Vijfeijken for his management throughout the essential improvement interval through which it superior the MUSA-3 system and obtained regulatory approval.
As the corporate strikes ahead, it can give attention to scientific adoption, producing proof and laying the muse for potential broader commercialization of the know-how.
